Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 11/2003

01-11-2003 | Original Article

l-Ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8–independent pathway

Authors: Jae Seung Kang, Daeho Cho, Young-In Kim, Eunsil Hahm, Yoolhee Yang, Daejin Kim, Daeyoung Hur, Hyunjeong Park, Saic Bang, Young Il Hwang, Wang Jae Lee

Published in: Cancer Immunology, Immunotherapy | Issue 11/2003

Login to get access

Abstract

l-Ascorbic acid (vitamin C) has been reported to play a role in the treatment and prevention of cancer. However, its specific mechanistic pathways remain obscure. This study was carried out to identify the sodium ascorbate–induced apoptotic pathway in B16F10 murine melanoma cells. Sodium ascorbate was found to induce the apoptosis of B16F10 murine melanoma in a time- and dose-dependent manner, and this was prevented by pretreatment with N-acetyl-l-cysteine (NAC), a well-known antioxidant. In fact, sodium ascorbate–treated B16F10 melanoma cells showed increased intracellular reactive oxygen species generation (ROS) levels. These results indicate that sodium ascorbate induced apoptosis in B16F10 murine melanoma cells by acting as a prooxidant. We examined the involvement of caspase-8 using a specific caspase-8 inhibitor (z-IETD-fmk) on the sodium ascorbate–induced apoptotic pathway. Cell death was found not to be inhibited by z-IETD-fmk treatment, indicating that sodium ascorbate–induced apoptosis is not mediated by caspase-8. In addition, we detected a reduction in the mitochondrial membrane potential during apoptosis and confirmed cytochrome-c release from mitochondria by immunoblotting. Taken together, it appears that the induction of a prooxidant state by sodium ascorbate and a subsequent reduction in mitochondrial membrane potential are involved in the apoptotic pathway of B16F10 murine melanoma cells, and that this occurs in a caspase-8–independent manner.
Literature
1.
go back to reference Afansev VN, Korol BA, Mantsygin YA (1986) Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Letter 194:347CrossRef Afansev VN, Korol BA, Mantsygin YA (1986) Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Letter 194:347CrossRef
2.
go back to reference Bram S, Froussard P, Guichard M, Jasmin C, Augery Y, Sinoussi-Barre F, Wray W (1980) Vitamin C preferential toxicity for malignant melanoma cells. Nature 284:629PubMed Bram S, Froussard P, Guichard M, Jasmin C, Augery Y, Sinoussi-Barre F, Wray W (1980) Vitamin C preferential toxicity for malignant melanoma cells. Nature 284:629PubMed
3.
go back to reference De Pauw-Gillet MC, Siwek B, Pozzi G, Sabbioni E, Bassleer RJ (1990) Control of B16F10 melanoma cells differentiation and proliferation by CuSO4 and vitamin C. Anticancer Res 10:391PubMed De Pauw-Gillet MC, Siwek B, Pozzi G, Sabbioni E, Bassleer RJ (1990) Control of B16F10 melanoma cells differentiation and proliferation by CuSO4 and vitamin C. Anticancer Res 10:391PubMed
4.
go back to reference De Pauw-Gillet MC, Siwek B, Pozzi G, Sabbioni E, Bassleer RJ (1990) Effects of Fe SO4 on B16F10 melanoma cells differentiation and proliferation. Anticancer Res 10:1029PubMed De Pauw-Gillet MC, Siwek B, Pozzi G, Sabbioni E, Bassleer RJ (1990) Effects of Fe SO4 on B16F10 melanoma cells differentiation and proliferation. Anticancer Res 10:1029PubMed
5.
go back to reference Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33PubMed Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33PubMed
6.
go back to reference Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487PubMed Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487PubMed
7.
go back to reference Gardiner NS, Duncan JR (1988) Enhanced prostaglandin synthesis as a mechanism for inhibition of melanoma cell growth by ascorbic acid. Prostaglandins Leukot Essent Fatty Acids 34:119PubMed Gardiner NS, Duncan JR (1988) Enhanced prostaglandin synthesis as a mechanism for inhibition of melanoma cell growth by ascorbic acid. Prostaglandins Leukot Essent Fatty Acids 34:119PubMed
8.
go back to reference Gardiner NS, Duncan JR (1989) Inhibition of murine melanoma growth by sodium ascorbate. J Nutr 119:586PubMed Gardiner NS, Duncan JR (1989) Inhibition of murine melanoma growth by sodium ascorbate. J Nutr 119:586PubMed
9.
go back to reference Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309PubMed Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309PubMed
10.
go back to reference Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8:267 Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8:267
11.
go back to reference Hahne M, Rimoldi D, Schroter M, Romero P, Schreiter M, French LE (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363PubMed Hahne M, Rimoldi D, Schroter M, Romero P, Schreiter M, French LE (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363PubMed
12.
go back to reference Huber D, Philipp J, Fontana A (1998) Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor beta-independent pathway of tumor cell-mediated immunosuppression. J Immunol 148:277 Huber D, Philipp J, Fontana A (1998) Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor beta-independent pathway of tumor cell-mediated immunosuppression. J Immunol 148:277
14.
go back to reference Kroemer, G., N. Zamzami, S. A. Susin (1997) Mitochondrial control of apoptosis. Immunol Today 18:44PubMed Kroemer, G., N. Zamzami, S. A. Susin (1997) Mitochondrial control of apoptosis. Immunol Today 18:44PubMed
15.
go back to reference Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95PubMed Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95PubMed
16.
go back to reference Liu X., Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell free extracts: requirement for dATP and cytochrome c. Cell 86:147PubMed Liu X., Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell free extracts: requirement for dATP and cytochrome c. Cell 86:147PubMed
17.
go back to reference Marczewska J, Koziorowska JH, Anuszewska EL (2000) Influence of ascorbic acid on cytotoxic activity of copper and iron ions in vitro. Acta Pol Pharm 57:415PubMed Marczewska J, Koziorowska JH, Anuszewska EL (2000) Influence of ascorbic acid on cytotoxic activity of copper and iron ions in vitro. Acta Pol Pharm 57:415PubMed
18.
go back to reference Mukherji B, Chakraborty NG (1995) Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 7:175PubMed Mukherji B, Chakraborty NG (1995) Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 7:175PubMed
19.
go back to reference Nicholson DW, Thornberry NA (1997) Caspases: killer proteases. Trends Biochem Sci 22:299PubMed Nicholson DW, Thornberry NA (1997) Caspases: killer proteases. Trends Biochem Sci 22:299PubMed
20.
go back to reference Nungester WJ, Ames AM (1948) The relationship between ascorbic acid and phagocytic activity. J Infect Dis 83:50 Nungester WJ, Ames AM (1948) The relationship between ascorbic acid and phagocytic activity. J Infect Dis 83:50
21.
go back to reference Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545PubMed Peter ME, Krammer PH (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545PubMed
22.
go back to reference Savill J, Fadok V, Henson P (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131PubMed Savill J, Fadok V, Henson P (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131PubMed
23.
go back to reference Siegel BV (1975) Enhancement of interferon production by poly(rl)poly(rC) in mouse cell cultures by ascorbic acid. Nature 254:531PubMed Siegel BV (1975) Enhancement of interferon production by poly(rl)poly(rC) in mouse cell cultures by ascorbic acid. Nature 254:531PubMed
24.
go back to reference Stockinger HE (1977) The case for carcinogen TLVs continues strong. Int J Occup Health Saf 46:54 Stockinger HE (1977) The case for carcinogen TLVs continues strong. Int J Occup Health Saf 46:54
25.
go back to reference Stone I (1980) The possible role of mega-ascorbate in the endogenous synthesis of interferon. Med Hypotheses 6:309PubMed Stone I (1980) The possible role of mega-ascorbate in the endogenous synthesis of interferon. Med Hypotheses 6:309PubMed
26.
go back to reference Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8:613PubMed Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8:613PubMed
28.
go back to reference Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277:445CrossRefPubMed Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277:445CrossRefPubMed
29.
go back to reference Victor VV, Guayerbas N, Puerto M, Medina S, De la Fuente M (2000) Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 46:89CrossRefPubMed Victor VV, Guayerbas N, Puerto M, Medina S, De la Fuente M (2000) Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 46:89CrossRefPubMed
30.
go back to reference Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ (2001) Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98:13884CrossRefPubMed Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ (2001) Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98:13884CrossRefPubMed
31.
go back to reference Wyllie AH, Morrid RG, Smith AL (1998) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67 Wyllie AH, Morrid RG, Smith AL (1998) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67
32.
go back to reference Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Pen T-I, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275:1129–1132 Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Pen T-I, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275:1129–1132
33.
go back to reference Zoratti M, Szabo I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241:139PubMed Zoratti M, Szabo I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241:139PubMed
Metadata
Title
l-Ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8–independent pathway
Authors
Jae Seung Kang
Daeho Cho
Young-In Kim
Eunsil Hahm
Yoolhee Yang
Daejin Kim
Daeyoung Hur
Hyunjeong Park
Saic Bang
Young Il Hwang
Wang Jae Lee
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 11/2003
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-003-0407-6

Other articles of this Issue 11/2003

Cancer Immunology, Immunotherapy 11/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine